A novel crosstalk between BRCA1 and sirtuin 1 in ovarian cancer
2014 · Scientific Reports · 34 citations
https://doi.org/10.1038/srep06666
F
Fangfang Bi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
1.4K
Citations
22
h-index
38
i10-index
Fangfang Bi is an academic researcher from China Medical University. The author has contributed to research in topics: RNA modifications and cancer & Cancer-related molecular mechanisms research & Epigenetics and DNA Methylation. The author has an h-index of 22, co-authored 51 publications.
ORCID: 0000-0002-0384-3965Papers by this author
worksPromoter hypomethylation, especially around the E26 transformation-specific motif, and increased expression of poly (ADP-ribose) polymerase 1 in BRCA-mutated serous ovarian cancer
2013 · BMC Cancer · 24 citations
https://doi.org/10.1186/1471-2407-13-90
Regulation of angiotensin II type 1 receptor expression in ovarian cancer: a potential role for BRCA1
2013 · Journal of Ovarian Research · 13 citations
https://doi.org/10.1186/1757-2215-6-89
Ovarian BDNF promotes survival, migration, and attachment of tumor precursors originated from p53 mutant fallopian tube epithelial cells
2020 · Oncogenesis · 13 citations
https://doi.org/10.1038/s41389-020-0243-y
Additional file 3 of Mitophagy-related long non-coding RNA signature predicts prognosis and drug response in Ovarian Cancer
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.24038707
Additional file 4 of Mitophagy-related long non-coding RNA signature predicts prognosis and drug response in Ovarian Cancer
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.24038710
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat